{
    "2018-12-26": [
        [
            {
                "time": "",
                "original_text": "72家险企四季度435次调研 涉及上市公司160家",
                "features": {
                    "keywords": [
                        "险企",
                        "四季度",
                        "调研",
                        "上市公司"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "保险",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "从美国仿制药企业兴衰看中外药企的估值差异和竞争策略:崛起和失落",
                "features": {
                    "keywords": [
                        "美国",
                        "仿制药",
                        "药企",
                        "兴衰",
                        "估值",
                        "竞争策略"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}